Associated Skincare Specialists

New Brighton, Minnesota 55112

0 studies enrolling now · 3 studies all time

What they study most

Alopecia Areata, Atopic Dermatitis, Ichthyosis

Studies at this site

• The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis — Completed
• A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata — Completed
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed